LGCmain
Indian Journal of Pathology and Microbiology
Home About us Instructions Submission Subscribe Advertise Contact e-Alerts Ahead Of Print Login 
Users Online: 248
Print this page  Email this page Bookmark this page Small font sizeDefault font sizeIncrease font size
BRIEF COMMUNICATION
Year : 2020  |  Volume : 63  |  Issue : 2  |  Page : 251-254

Management of transfusion needs in a case of immunizing anti-M antibody in a patient with acute myeloid leukemia


Department of Transfusion Medicine, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India

Correspondence Address:
Priti Desai
Department of Transfusion Medicine, Tata Memorial Hospital, 5th Floor Service Block, Dr E Borges Road, Parel Mumbai - 400 012, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/IJPM.IJPM_166_19

Rights and Permissions

Anti-M is a relatively common “naturally occurring” antibody. Unexpected alloantibodies in patient's serum other than ABO isoagglutinins (e.g., anti-M) may cause a discrepancy in the reverse grouping. As long as anti-M does not react at 37°C, it is clinically insignificant for transfusion. However, we found this antibody to be of “immunizing” type which was reactive at 37°C and AHG phase and showing problems in blood grouping and crossmatch. This antibody had both IgM and IgG components. When “M” antibodies active at 37°C are encountered, antigen-negative or red cells that are compatible with an indirect antiglobulin test should be provided.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed140    
    Printed2    
    Emailed0    
    PDF Downloaded14    
    Comments [Add]    

Recommend this journal